BBR can improve diabetic retinopathy in type I and II diabetic animals receiving insulin therapy, reducing neovasculature and neural cell damage in the eyes and therefore supplemented the therapeutic outcome of insulin therapy. The gene discussed is INS; the disease is diabetic retinopathy.